All In MedTech

Device Trial Radar · NCT04177212

Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles

Prospective, Multicenter, Parallel-group, Evaluator-blind, Randomized Study to Investigate the Effectiveness and Safety of MRZF111 in the Treatment of décolleté Wrinkles

Last checked: Nov 20, 2026Latest source record: Dec 26, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 117 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

117

Actual

Start

Dec 4, 2019

Primary completion

Nov 17, 2020

Study completion Feb 23, 2021

Sponsor

Lead sponsor
Merz Aesthetics GmbHNot on our public-company list
Sponsor type
Industry
Collaborators
Merz Pharmaceuticals GmbH
First posted
Nov 26, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the effectiveness and safety of MRZF111 treatment for improvement of décolleté wrinkles as assessed on the Merz Aesthetics Scales (MAS) Décolleté Wrinkles-At Rest.

Conditions

  • Décolleté Wrinkles

Interventions

  • MRZF111Device

    MRZF111 kit consisting of one syringe of RADIESSE® Volume injectable implant, injection needles and additional components. Physiological saline solution (0.9% NaCl) is used to dilute Radiesse Volume by 1:2. Radiesse consists of calcium hydroxylapatite particles suspended in an aqueous-based gel carrier.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Responder Rate for Décolleté Wrinkles According to the Merz Aesthetics Scale (MAS)-At Rest Scale as Assessed by the Blinded Live RaterTime frame: 16 weeks after the last treatment on Week 16 (at Week 32)

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Merz Investigational Site #0490189

    Bad Soden, Germany

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.